MELANIE OLIVER: Open Payments
NPI 1528389723 · BOUNTIFUL, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,141 in 77 payments from 20 companies in 2025. Trend: 2023 $1,191 · 2024 $1,184 · 2025 $1,141
Food & beverage: $1,141
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $308 |
| Lilly USA, LLC | 17 | $188 |
| Amgen Inc. | 5 | $74 |
| Edwards Lifesciences Corporation | 2 | $64 |
| Astellas Pharma US Inc | 3 | $55 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $54 |
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $47 |
| Novartis Pharmaceuticals Corporation | 2 | $38 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
Products named: VRAYLAR, QULIPTA, MOUNJARO, KISUNLA, JARDIANCE, OTEZLA, Veozah, CAPLYTA.
Industry payments across UT — which companies pay providers there.
